Preemptive DLI Without Withdrawal of Immunosuppression to Promote Complete Donor T-Cell Chimerism Results in Favorable Outcomes for High-Risk Older Recipients of Alemtuzumab-Containing Reduced-Intensity Unrelated Donor Allogeneic Transplant: A Prospective Phase II Trial

Bone Marrow Transplantation - United Kingdom
doi 10.1038/bmt.2014.2
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Phase II Clinical Trial of Etanercept Plus Extracorporeal Photopheresis GVHD Prophylaxis Following Unrelated Donor Reduced Intensity Transplant

Biology of Blood and Marrow Transplantation
TransplantationHematology
2015English

Patients With Early Initiation of DLI for Mixed Donor Chimerism Were More Likely to Have Improvement in Donor Chimerism

Biology of Blood and Marrow Transplantation
TransplantationHematology
2012English

Randomized Phase II Trial Comparing Two Dose Levels of Thymoglobulin in Patients Undergoing Unrelated Donor Hematopoietic Cell Transplant

Leukemia and Lymphoma
Cancer ResearchOncologyHematology
2011English

Donor Race and Outcomes in Kidney Transplant Recipients

Clinical Transplantation
Transplantation
2012English

A Randomised Controlled Trial of Total Immunosuppression Withdrawal in Stable Liver Transplant Recipients

Gut
Gastroenterology
2007English

Unrelated Donor Transplantation in Children With Thalassemia Using Reduced Intensity Conditioning - The URTH Trial

Biology of Blood and Marrow Transplantation
TransplantationHematology
2018English

Durable Graft-Versus-Leukaemia Effects Without Donor Lymphocyte Infusions - Results of a Phase II Study of Sequential T-Replete Allogeneic Transplantation for High-Risk Acute Myeloid Leukaemia and Myelodysplasia

British Journal of Haematology
Hematology
2017English

Rapid Induction of Complete Donor Chimerism by the Use of a Reduced-Intensity Conditioning Regimen Composed of Fludarabine and Melphalan in Allogeneic Stem Cell Transplantation for Metastatic Solid Tumors

Blood
BiochemistryImmunologyCell BiologyHematology
2003English

Reduced Toxicity Conditioning With Busulfan, Fludarabine, Alemtuzumab and Allogeneic Stem Cell Transplantation From HLA-Matched Sibling Donors in Children With High Risk Sickle Cell Disease Results in Long Term Donor Chimerism and Low Incidence of aGVHD

Biology of Blood and Marrow Transplantation
TransplantationHematology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy